ENTRY       D10430                      Drug
NAME        Treprostinil diolamine (USAN);
            Orenitram (TN)
PRODUCT     ORENITRAM (United Therapeutics Corporation)
FORMULA     C23H34O5. C4H11NO2
EXACT_MASS  495.3196
MOL_WEIGHT  495.6487
CLASS       Blood modifier agent
             DG01950  Antithrombotic agent
              DG01712  Antiplatelet agent
            Hormonal agent
             DG01961  Prostaglandin derivative
              DG01810  Prostacycline derivative
            Metabolizing enzyme substrate
             DG02918  CYP2C8 substrate
REMARK      ATC code: B01AC21
            Chemical structure group: DG00161
            Product (DG00161): D06213<JP/US> D10430<US>
EFFICACY    Antihypertensive, Prostaglandin I2 receptor agonist
  DISEASE   Pulmonary arterial hypertension [DS:H01621]
COMMENT     Prostacycline derivative
            Treatment of pulmonary arterial hypertension
TARGET      PTGIR [HSA:5739] [KO:K04263]
  PATHWAY   hsa04080(5739)  Neuroactive ligand-receptor interaction
            hsa04270(5739)  Vascular smooth muscle contraction
            hsa04611(5739)  Platelet activation
METABOLISM  Enzyme: CYP2C8 [HSA:1558]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AC Platelet aggregation inhibitors excl. heparin
                 B01AC21 Treprostinil
                  D10430  Treprostinil diolamine (USAN) &lt;US&gt;
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                DG00161  Treprostinil
                 D10430  Treprostinil diolamine
             Hormonal agent
              DG01961  Prostaglandin derivative
               DG01810  Prostacycline derivative
                DG00161  Treprostinil
                 D10430  Treprostinil diolamine
             Metabolizing enzyme substrate
              DG02918  CYP2C8 substrate
               DG00161  Treprostinil
                D10430  Treprostinil diolamine
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Prostacyclin
                PTGIR
                 D10430  Treprostinil diolamine (USAN) &lt;US&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10430
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                DG00161  Treprostinil
             Hormonal agent
              DG01961  Prostaglandin derivative
               DG01810  Prostacycline derivative
                DG00161  Treprostinil
             Metabolizing enzyme substrate
              DG02918  CYP2C8 substrate
               DG00161  Treprostinil
DBLINKS     CAS: 830354-48-8
            PubChem: 172232523
ATOM        35
            1   N1b N    33.9271  -15.3198
            2   C1b C    32.6679  -16.0194
            3   C1b C    35.1164  -16.0194
            4   C1b C    31.4787  -15.3198
            5   C1b C    36.3056  -15.3198
            6   O1a O    30.2895  -16.0194
            7   O1a O    37.5648  -16.0194
            8   C1x C    16.8700  -18.6900
            9   C1y C    17.6400  -19.9500
            10  C1y C    18.9700  -19.4600
            11  C1y C    18.9700  -18.0600
            12  C1y C    17.6400  -17.5700
            13  C1b C    20.1600  -20.2300
            14  C1b C    21.3500  -19.4600
            15  C1c C    22.5400  -20.2300
            16  C1b C    23.7300  -19.4600
            17  O1a O    22.5400  -21.6300
            18  C1b C    24.9900  -20.2300
            19  C1b C    26.1800  -19.4600
            20  C1b C    27.3700  -20.2300
            21  C1a C    28.5600  -19.4600
            22  O1a O    17.1500  -21.2800
            23  C1x C    20.0200  -17.1500
            24  C8y C    19.8100  -15.7500
            25  C8y C    18.4800  -15.2600
            26  C1x C    17.4300  -16.1700
            27  C8x C    20.8600  -14.9100
            28  C8x C    20.6500  -13.5100
            29  C8x C    19.3200  -13.0200
            30  C8y C    18.2700  -13.9300
            31  O2a O    17.0800  -13.2300
            32  C1b C    15.8900  -13.9300
            33  C6a C    14.7000  -13.2300
            34  O6a O    13.4400  -13.9300
            35  O6a O    14.7000  -11.8300
BOND        36
            1     1   2 1
            2     1   3 1
            3     2   4 1
            4     3   5 1
            5     4   6 1
            6     5   7 1
            7     8   9 1
            8     9  10 1
            9    10  11 1
            10   11  12 1
            11    8  12 1
            12   10  13 1 #Up
            13   13  14 1
            14   14  15 1
            15   15  16 1
            16   15  17 1 #Down
            17   16  18 1
            18   18  19 1
            19   19  20 1
            20   20  21 1
            21    9  22 1 #Down
            22   11  23 1 #Down
            23   23  24 1
            24   24  25 1
            25   25  26 1
            26   12  26 1 #Down
            27   24  27 2
            28   27  28 1
            29   28  29 2
            30   29  30 1
            31   25  30 2
            32   31  30 1
            33   31  32 1
            34   32  33 1
            35   33  34 1
            36   33  35 2
///
